Candidemia in a tertiary care hospital: Epidemiology and factors influencing mortality

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 22, Issue 4, 2003, Pages 254-257

  Alonso Valle, H ^b   Acha, O ^b   Garcia Palomo J D ^b   Farinas Alvarez C ^a   Fernandez Mazarrasa C ^b   Farinas M C ^b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CEFOTAXIME; CLOXACILLIN; FLUCONAZOLE; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ARTICLE; BACTEREMIA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDIASIS; CENTRAL VENOUS CATHETER; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE COURSE; FEMALE; HOSPITAL INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEPSIS;

EID: 0038583771     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-003-0890-x     Document Type: Article

References (16)

1. Klein JJ, Watanakunokorn C (1979) Candida hospital acquired fungemia: its natural course and clinical significance. Am J Med 67:51-58
2. Fridkin SK, Jarvis WR (1996) Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 9:499-511
3. Jarvis WR (1995) Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 20:1526
4. Banerjee SN, Emori TG, Culver DH, Gaynes RP, Jarvis WR, Horan T, et al. (1991) Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 91 (Suppl 3B):86-89
5. Wey SB, Motomi M, Pfaller MA, Woolson RF, Wenzel RP (1989) Risk factors for hospital-acquired candidemia: a matched case-control study. Arch Intern Med 149:2349-2353
6. Wey S, Mori M, Pfaller MA, Woolson RF, Wenzel RP (1988) Hospital acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 148:2642-2645
7. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC (1992) Candidemia in a tertiary care hospital: epidemiology, risk factors and predictors of mortality. Clin Infect Dis 15:414-421
8. Edwards JE Jr, Bodey GP, Bowden RA, Buchner T, de Pauw BE, Filler SG, et al. (1997) International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis 25:43-59
9. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) Centers for Disease Control (CDC) definitions for nosocomial infection. Am J Infect Control 16:128-140
10. McCabe WR, Jackson GC (1962) Gram-negative bacteremia, II: clinical, laboratory, and therapeutic observations. Arch Intern Med 110:856-864
11. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117-123
12. Harvey RL, Myers JP (1987) Nosocomial fungemia in a large teaching hospital. Arch Intern Med 147:2117-2120
13. Vincent JL, Bihari DJ (1995) The prevalence of nosocomial infections in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIIC) Study. JAMA 274:639-644
14. Abi-Said D, Anaissie E, Uzon O, Raad I, Pinzcowski H, Vartivarian S (1997) The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 24:1122
15. Weems JJ Jr (1992) Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations and antimicrobial susceptibility. Clin Infect Dis 14:756-766
16. Pfaller MA, Jones RN, Doern GV, Sader HS, Hollis RJ, Messer SA (1998) International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY program. J Clin Microbiol 36:1886-1889